Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | navitoclax:MST-312 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | SU11274 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.7 |
mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.01 | 0.7 |
mRNA | BRD-K71781559 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.012 | 0.8 |